74 related articles for article (PubMed ID: 12428418)
1. [Vaccinia virus as a vector for transduction of dendritic cells].
Nĕmecková S; Kutinová L; Hainz P; Subrtová J; Otáhal P; Gabriel P
Cas Lek Cesk; 2002 Sep; 141 Suppl():23-5. PubMed ID: 12428418
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant effect of dendritic cells transduced with recombinant vaccinia virus expressing HPV16-E7 is inhibited by co-expression of IL12.
Mackova J; Kutinova L; Hainz P; Krystofova J; Sroller V; Otahal P; Gabriel P; Nemeckova S
Int J Oncol; 2004 Jun; 24(6):1581-8. PubMed ID: 15138603
[TBL] [Abstract][Full Text] [Related]
3. Lentivirally transduced dendritic cells as a tool for cancer immunotherapy.
Breckpot K; Dullaers M; Bonehill A; van Meirvenne S; Heirman C; de Greef C; van der Bruggen P; Thielemans K
J Gene Med; 2003 Aug; 5(8):654-67. PubMed ID: 12898635
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cells infected with a vaccinia virus interleukin-2 vector secrete high levels of IL-2 and can become efficient antigen presenting cells that secrete high levels of the immunostimulatory cytokine IL-12.
Mukherjee S; Upham JW; Ramshaw I; Bundell C; van Bruggen I; Robinson BW; Nelson DJ
Cancer Gene Ther; 2003 Aug; 10(8):591-602. PubMed ID: 12872141
[TBL] [Abstract][Full Text] [Related]
5. Enhanced transduction of mouse bone marrow-derived dendritic cells by repetitive infection with self-complementary adeno-associated virus 6 combined with immunostimulatory ligands.
Aldrich WA; Ren C; White AF; Zhou SZ; Kumar S; Jenkins CB; Shaw DR; Strong TV; Triozzi PL; Ponnazhagan S
Gene Ther; 2006 Jan; 13(1):29-39. PubMed ID: 16136165
[TBL] [Abstract][Full Text] [Related]
6. Sensitization to enhanced green fluorescence protein minor histocompatibility antigen by gene transduction into dendritic cells and peritoneal exudate macrophages.
Satoh E; Li XK; Hara Y; Ogata K; Guo L; Kitazawa Y; Funeshima-Fuji N; Satoh T; Miyagi T; Sugiura W; Yamamoto N; Teramoto K; Arii S; Kimura H
Transpl Immunol; 2007 Nov; 18(2):73-84. PubMed ID: 18005848
[TBL] [Abstract][Full Text] [Related]
7. Transduction with a fiber-modified adenoviral vector is superior to non-viral nucleofection for expressing tumor-associated Ag mucin-1 in human DC.
van Leeuwen EB; Cloosen S; Senden-Gijsbers BL; Germeraad WT; Bos GM
Cytotherapy; 2006; 8(1):36-46. PubMed ID: 16627343
[TBL] [Abstract][Full Text] [Related]
8. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
[TBL] [Abstract][Full Text] [Related]
9. Immune characterization of clinical grade-dendritic cells generated from cancer patients and genetically modified by an ALVAC vector carrying MAGE minigenes.
Trakatelli M; Toungouz M; Lambermont M; Heenen M; Velu T; Bruyns C
Cancer Gene Ther; 2005 Jun; 12(6):552-9. PubMed ID: 15665821
[TBL] [Abstract][Full Text] [Related]
10. Studies on the most efficient vector systems for gene transduction into dendritic cells.
Satoh E; Yan H; Miyagi T; Li XK; Sugiura W; Yamamoto N; Teramoto K; Arii S; Kimura H
Transplant Proc; 2005; 37(1):12-4. PubMed ID: 15808530
[TBL] [Abstract][Full Text] [Related]
11. From pathogen to medicine: HIV-1-derived lentiviral vectors as vehicles for dendritic cell based cancer immunotherapy.
Dullaers M; Thielemans K
J Gene Med; 2006 Jan; 8(1):3-17. PubMed ID: 16288497
[TBL] [Abstract][Full Text] [Related]
12. Generation of human dendritic cells that simultaneously secrete IL-12 and have migratory capacity by adenoviral gene transfer of hCD40L in combination with IFN-gamma.
Knippertz I; Hesse A; Schunder T; Kämpgen E; Brenner MK; Schuler G; Steinkasserer A; Nettelbeck DM
J Immunother; 2009 Jun; 32(5):524-38. PubMed ID: 19609245
[TBL] [Abstract][Full Text] [Related]
13. Expression of aberrantly glycosylated tumor mucin-1 on human DC after transduction with a fiber-modified adenoviral vector.
van Leeuwen EB; Cloosen S; Senden-Gijsbers BL; Agervig Tarp M; Mandel U; Clausen H; Havenga MJ; Duffour MT; García-Vallejo JJ; Germeraad WT; Bos GM
Cytotherapy; 2006; 8(1):24-35. PubMed ID: 16627342
[TBL] [Abstract][Full Text] [Related]
14. Human dendritic cells: natural adjuvants in antitumor immunotherapy.
Di Nicola M; Anichini A; Mortarini R; Bregni M; Parmiani G; Gianni AM
Cytokines Cell Mol Ther; 1998 Dec; 4(4):265-73. PubMed ID: 10068060
[TBL] [Abstract][Full Text] [Related]
15. Side-by-side comparison of lentivirally transduced and mRNA-electroporated dendritic cells: implications for cancer immunotherapy protocols.
Dullaers M; Breckpot K; Van Meirvenne S; Bonehill A; Tuyaerts S; Michiels A; Straetman L; Heirman C; De Greef C; Van Der Bruggen P; Thielemans K
Mol Ther; 2004 Oct; 10(4):768-79. PubMed ID: 15451461
[TBL] [Abstract][Full Text] [Related]
16. Dendritic cells transduced with recombinant adenoviruses induce more efficient anti-tumor immunity than dendritic cells pulsed with peptide.
Oh ST; Kim CH; Park MY; Won EH; Sohn HJ; Cho HI; Kang WK; Hong YK; Kim TG
Vaccine; 2006 Apr; 24(15):2860-8. PubMed ID: 16443309
[TBL] [Abstract][Full Text] [Related]
17. Analyses of recombinant vaccinia and fowlpox vaccine vectors expressing transgenes for two human tumor antigens and three human costimulatory molecules.
Tsang KY; Palena C; Yokokawa J; Arlen PM; Gulley JL; Mazzara GP; Gritz L; Yafal AG; Ogueta S; Greenhalgh P; Manson K; Panicali D; Schlom J
Clin Cancer Res; 2005 Feb; 11(4):1597-607. PubMed ID: 15746065
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the vector systems for gene transduction into rat dendritic cells and peritoneal exudate cells.
Satoh E; Hara Y; Fuji N; Li XK; Teramoto K; Arii S; Kimura H
Transplant Proc; 2005 May; 37(4):1953-6. PubMed ID: 15919516
[TBL] [Abstract][Full Text] [Related]
19. DNA viruses and genetic modification of dendritic cells.
Jenne L; Steinkasserer A
Arch Immunol Ther Exp (Warsz); 2002; 50(4):273-7. PubMed ID: 12371623
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cells modified to express fractalkine/CX3CL1 in the treatment of preexisting tumors.
Nukiwa M; Andarini S; Zaini J; Xin H; Kanehira M; Suzuki T; Fukuhara T; Mizuguchi H; Hayakawa T; Saijo Y; Nukiwa T; Kikuchi T
Eur J Immunol; 2006 Apr; 36(4):1019-27. PubMed ID: 16525992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]